Peak6 Investments LLC Exelixis, Inc. Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $18,579 - $22,824	-905 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $3,733 - $5,034	-203 Reduced 18.32%	905 $18,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $19,822 - $25,835	-959 Reduced 46.4%	1,108 $27,000
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $64,375 - $107,239	-3,911 Reduced 65.42%	2,067 $49,000
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $124,139 - $187,153	-8,585 Reduced 58.95%	5,978 $103,000
Q4 2019 Feb 13, 2020	SELL	$15.15 - $18.89 $131,502 - $163,965	-8,680 Reduced 37.34%	14,563 $257,000
Q3 2019 Nov 08, 2019	BUY	$17.68 - $22.65 $187,248 - $239,886	10,591 Added 83.71%	23,243 $411,000
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $239,502 - $313,137	12,652 New	12,652 $270,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.